Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction

Behavioural Pharmacology

Volumn 22, Issue 8, 2011, Pages 779-784

  Bah, Thierno Madjou ^a,b   Kaloustian, Sévan ^a,b   Rousseau, Guy ^a,b   Godbout, Roger ^a,b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cytokines; depression; myocardial infarction; pentoxifylline; rat

Indexed keywords

INTERLEUKIN 1BETA; PENTOXIFYLLINE; SUCROSE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; LIMBIC SYSTEM; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MALE; MYOCARDIAL INFARCTION; PENTOXIFYLLINE; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING;

EID: 80855139560     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32834d1385     Document Type: Article

References (50)

1. Ahern DK, Gorkin L, Anderson JL, Tierney C, Hallstrom A, Ewart C, et al. (1990). Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 66:59-62. (Pubitemid 20215719)
2. Anisman H, Merali Z (1999). Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 461:199-233.
3. Bah TM, Laplante F, Wann B, Sullivan R, Rousseau G, Godbout R (2010). Paradoxical sleep insomnia and decreased cholinergic neurons after myocardial infarction in the rats. Sleep 33:1703-1710.
4. Bah TM, Benderdour M, Kaloustian S, Karam R, Rousseau G, Godbout R (2011). Escitalopram reduces circulating proinflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post cardiac infarct depression. Behav Brain Res 225:243-251.
5. Belosjorow S, Bolle I, Duschin A, Heusch G, Schulz R (2003). TNF-a antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. Am J Physiol 284:H927-H930. (Pubitemid 36228241)
6. Bonaccorso S, Maier SF, Meltzer HY, Maes M (2003). Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1 beta: relevance for affective disorders. J Affect Disord 77:143-148. (Pubitemid 37363342)
7. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, et al. (2001). Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88:337-341. (Pubitemid 32823291)
8. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 98:12796-12801. (Pubitemid 33020024)
9. Danjo W, Fujimura N, Ujike Y (2008). Effect of pentoxifylline on diaphragmatic contractility in septic rats. Acta Med Okayama 62:101-107.
10. Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, et al. (2004). Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 37:51-61. (Pubitemid 38900528)
11. Deuchar GA, Opie LH, Lecour S (2007). TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Sci 80:1686-1691. (Pubitemid 46463923)
12. Forrester AW, Lipsey JR, Teitelbaum ML, DePaulo JR, Andrzejewski PL (1992). Depression following myocardial infarction. Int J Psychiatry Med 22:33-46.
13. Frasure-Smith N, Lesperance F, Talajic M (1993). Depression following myocardial infarction. Impact on 6-month survival. JAMA 270:1819-1825. (Pubitemid 23301435)
14. Frasure-Smith N, Lesperance F, Talajic M (1995). The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 14:388-398.
15. Gould E, Tanapat P (1999). Stress and hippocampal neurogenesis. Biol Psychiatry 46:1472-1479.
16. Guck TP, Kavan MG, Elsasser GN, Barone EJ (2001). Assessment and treatment of depression following myocardial infarction. Am Fam Physician 64: 641-648.
17. Gutierrez-Reyes G, Lopez-Ortal P, Sixtos S, Cruz S, Ramirez-Iglesias MT, Gutierrez-Ruiz MC, et al. (2006). Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C. Scand J Immunol 63:461-467. (Pubitemid 43978861)
18. Ivanova SA, Semke VY, Vetlugina TP, Rakitina NM, Kudyakova TA, Simutkin GG (2007). Signs of apoptosis of immunocompetent cells in patients with depression. Neurosci Behav Physiol 37:527-530. (Pubitemid 46784981)
19. Kaloustian S, Wann BP, Bah TM, Girard SA, Apostolakis A, Ishak S, et al. (2008). Apoptosis time course in the limbic system after myocardial infarction in the rat. Brain Res 1216:87-91.
20. Kaloustian S, Bah TM, Rondeau I, Mathieu S, Lada-Moldovan L, Ryvlin P, et al. (2009). Tumor necrosis factor-alpha participates in apoptosis in the limbic system after myocardial infarction. Apoptosis 14:1308-1316.
21. Koo JW, Duman RS (2008). IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 105:751-756. (Pubitemid 351171780)
22. Lacosta S, Merali Z, Anisman H (1998). Influence of interleukin-1X on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology 137:351-361. (Pubitemid 28305371)
23. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG (2002). Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105:1049-1053. (Pubitemid 34212612)
24. Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, Zhang HT (2009). Antidepressant-and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsycho-pharmacology 34:2404-2419.
25. Lucassen PJ, Müller MB, Holsboer F, Bauer J, Holtrop A, Wouda J, et al. (2001). Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 158:453-468. (Pubitemid 32158608)
26. Lucassen PJ, Fuchs E, Czéh B (2004). Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55:789-796. (Pubitemid 38429869)
27. Lucassen PJ, Heine VM, Muller MB, van der Beek EM, Wiegant VM, De Kloet ER, et al. (2006). Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 5:531-546. (Pubitemid 44523871)
28. Lucki I (1997). The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8 (6-7):523-532. (Pubitemid 27504702)
29. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110. (Pubitemid 32042912)
30. Meneses R, Almeida MC, Abecasis J, Arroja I, Carvalho A, Aleixo A (2007). Depression in patients with myocardial infarction. Rev Port Cardiol 26: 1143-1165. (Pubitemid 351211675)
31. Moreau JL (1997). Validation of an animal model of anhedonia, a major symptom of depression. Encephale 23:280-289. (Pubitemid 27448688)
32. Papp M, Willner P, Muscat R (1991). An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 104:255-259.
33. Politi P, Brondino N, Emanuele E (2008). Increased proapoptotic serum activity in patients with chronic mood disorders. Arch Med Res 39:242-245. (Pubitemid 350299618)
34. Porsolt RD (1979). Animal model of depression. Biomedicine 30:139-140. (Pubitemid 9235293)
35. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391.
36. Raetsch C, Jia JD, Boigk G, Bauer M, Hahn EG, Riecken EO, et al. (2002). Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut 50:241-247. (Pubitemid 34087939)
37. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24-31. (Pubitemid 43083561)
38. Redei EE, Ahmadiyeh N, Baum AE, Sasso DA, Slone JL, Solberg LC, et al. (2001). Novel animal models of affective disorders. Semin Clin Neuropsy-chiatry 6:43-67.
39. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U (2005). Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res 162:127-134. (Pubitemid 40731540)
40. Rygula R, Abumaria N, Flugge G, Hiemke C, Fuchs E, Ruther E, et al. (2006). Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav Pharmacol 17:19-29. (Pubitemid 43068381)
41. Simen BB, Duman CH, Simen AA, Duman RS (2006). TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 59:775-785.
42. Szuster-Ciesielska A, Slotwinska M, Stachura A, Marmurowska-Michalowska H, Dubas-Slemp H, Bojarska-Junak A, et al. (2008). Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:686-694. (Pubitemid 351312366)
43. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S (2004). Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 25:77-107. (Pubitemid 39582717)
44. Uguz F, Akman C, Kucuksarac S, Tufekci O (2009). Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 63:50-55.
45. Wann BP, Boucher M, Kaloustian S, Nim S, Godbout R, Rousseau G (2006). Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry 59:430-433. (Pubitemid 43289222)
46. Wann BP, Bah TM, Boucher M, Courtemanche J, Le Marec N, Rousseau G, et al. (2007). Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J Psychiatry Neurosci 32:11-16. (Pubitemid 46276296)
47. Wann BP, Bah TM, Kaloustian S, Boucher M, Dufort AM, Le Marec N, et al. (2009). Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline. J Psychopharmacol 23:451-459.
48. West AP (1990). Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 14:863-877. (Pubitemid 20373158)
49. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by tricyclic antidepressant. Psychopharmacology 93:358-364. (Pubitemid 17160661)
50. Willner P, Muscat R, Papp M (1992). Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16: 525-534.